1 resultaten
Goedgekeurd WMOWerving gestopt
We hypothesize that patients with a HER2-negative primary tumor but with at least one HER2-positive CTC benefit from HER2 targeted treatment with trastuzumab
Overzicht van medisch-wetenschappelijk onderzoek in Nederland